It will get up. There will be fluctuations in the short term, and it is normal to continue to fall, but it is optimistic in the medium and long term and will have very good returns in the long term. The pharmaceutical industry is a good track, and this fund is also a good fund for the pharmaceutical industry, with good future prospects.

The trend of short-term funds is influenced by many factors, but medical-related funds are worth our long-term investment, and the rate of return will never be low.

In fact, the medical industry includes many sub-industries, such as medical services, biopharmaceuticals, medical devices and so on.

Each sub-industry is at a different stage of development and has different investment logic. Accordingly, the medical industry has large and small investment opportunities every year.

However, the research of the medical industry is very difficult, and it is very close to the policy except for some professional-related knowledge. For example, as we all know, once some drugs are included in the scope of centralized mining, their drug prices may be reduced by nearly 90%, and the profits of enterprises will be greatly tested in an instant.

For an industry that has investment opportunities every year, but the research is extremely difficult. We can honestly buy relevant medical funds and then honestly hold the foundation.

Therefore, if you buy in a reasonable position, the yield will not be low in the long run.

abstract

In the long run, medicine is as specific as technology and has unlimited potential.

In the short term, China is now entering an aging society, and the proportion of the elderly population will increase sharply in ten years.

These old people came here by the east wind of reform and opening up, and they are basically above the middle class. The demand for medical and old-age services can be imagined.

So, can the medical fund get up later?